140 related articles for article (PubMed ID: 22763242)
1. Autophagy and reactive oxygen species modulate cytotoxicity induced by suppression of ATM kinase activity in head and neck cancer cells.
Lin CS; Wang YC; Huang JL; Hung CC; Chen JY
Oral Oncol; 2012 Nov; 48(11):1152-8. PubMed ID: 22763242
[TBL] [Abstract][Full Text] [Related]
2. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
[TBL] [Abstract][Full Text] [Related]
3. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.
Qi Y; Schoene NW; Lartey FM; Cheng WH
J Biol Chem; 2010 Oct; 285(43):33010-33017. PubMed ID: 20709753
[TBL] [Abstract][Full Text] [Related]
4. Ataxia-telangiectasia mutated (ATM) participates in the regulation of ionizing radiation-induced cell death via MAPK14 in lung cancer H1299 cells.
Liang N; Zhong R; Hou X; Zhao G; Ma S; Cheng G; Liu X
Cell Prolif; 2015 Oct; 48(5):561-72. PubMed ID: 26269117
[TBL] [Abstract][Full Text] [Related]
5. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
Veuger SJ; Durkacz BW
DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
[TBL] [Abstract][Full Text] [Related]
6. DNA damage caused by metal nanoparticles: involvement of oxidative stress and activation of ATM.
Wan R; Mo Y; Feng L; Chien S; Tollerud DJ; Zhang Q
Chem Res Toxicol; 2012 Jul; 25(7):1402-11. PubMed ID: 22559321
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription.
Khalil HS; Tummala H; Hupp TR; Zhelev N
Exp Biol Med (Maywood); 2012 Jun; 237(6):622-34. PubMed ID: 22728709
[TBL] [Abstract][Full Text] [Related]
8. Targeting the DNA double strand break repair machinery in prostate cancer.
Shaheen FS; Znojek P; Fisher A; Webster M; Plummer R; Gaughan L; Smith GC; Leung HY; Curtin NJ; Robson CN
PLoS One; 2011; 6(5):e20311. PubMed ID: 21629734
[TBL] [Abstract][Full Text] [Related]
9. ATM-dependent hyper-radiosensitivity in mammalian cells irradiated by heavy ions.
Xue L; Yu D; Furusawa Y; Cao J; Okayasu R; Fan S
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):235-43. PubMed ID: 19695441
[TBL] [Abstract][Full Text] [Related]
10. Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy.
Crescenzi E; Palumbo G; de Boer J; Brady HJ
Clin Cancer Res; 2008 Mar; 14(6):1877-87. PubMed ID: 18347191
[TBL] [Abstract][Full Text] [Related]
11. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
12. Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1.
Tripathi DN; Chowdhury R; Trudel LJ; Tee AR; Slack RS; Walker CL; Wogan GN
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):E2950-7. PubMed ID: 23878245
[TBL] [Abstract][Full Text] [Related]
13. DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.
Svirnovski AI; Serhiyenka TF; Kustanovich AM; Khlebko PV; Fedosenko VV; Taras IB; Bakun AV
Exp Oncol; 2010 Dec; 32(4):258-62. PubMed ID: 21270755
[TBL] [Abstract][Full Text] [Related]
14. MutL homolog 1 contributes to temozolomide-induced autophagy via ataxia-telangiectasia mutated in glioma.
Zou Y; Wang Q; Wang W
Mol Med Rep; 2015 Jun; 11(6):4591-6. PubMed ID: 25646660
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide induces autophagy via ATM‑AMPK‑ULK1 pathways in glioma.
Zou Y; Wang Q; Li B; Xie B; Wang W
Mol Med Rep; 2014 Jul; 10(1):411-6. PubMed ID: 24737504
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics reveal ATM kinase-dependent exchange in DNA damage response complexes.
Choi S; Srivas R; Fu KY; Hood BL; Dost B; Gibson GA; Watkins SC; Van Houten B; Bandeira N; Conrads TP; Ideker T; Bakkenist CJ
J Proteome Res; 2012 Oct; 11(10):4983-91. PubMed ID: 22909323
[TBL] [Abstract][Full Text] [Related]
17. The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt.
Li Y; Yang DQ
Mol Cancer Ther; 2010 Jan; 9(1):113-25. PubMed ID: 20053781
[TBL] [Abstract][Full Text] [Related]
18. The influence of ATM, ATR, DNA-PK inhibitors on the cytotoxic and genotoxic effects of dibenzo[def,p]chrysene on human hepatocellular cancer cell line HepG2.
Spryszyńska S; Smok-Pieniążek A; Ferlińska M; Roszak J; Nocuń M; Stępnik M
Mutat Res Genet Toxicol Environ Mutagen; 2015 Sep; 791():12-24. PubMed ID: 26338538
[TBL] [Abstract][Full Text] [Related]
19. G-quadruplex ligand SYUIQ-5 induces autophagy by telomere damage and TRF2 delocalization in cancer cells.
Zhou WJ; Deng R; Zhang XY; Feng GK; Gu LQ; Zhu XF
Mol Cancer Ther; 2009 Dec; 8(12):3203-13. PubMed ID: 19996277
[TBL] [Abstract][Full Text] [Related]
20. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.
Zhang T; Shen Y; Chen Y; Hsieh JT; Kong Z
Int J Radiat Biol; 2015 Apr; 91(4):368-78. PubMed ID: 25585815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
